SSR Mining Inc. (TSE:SSRM) shares hit a new 52-week high on Wednesday . The company traded as high as C$13.45 and last traded at C$13.40, with a volume of 87157 shares trading hands. The stock had previously closed at C$13.16.
A number of research analysts have weighed in on the company. National Bank Financial decreased their price objective on SSR Mining from C$18.00 to C$17.75 in a report on Friday, May 11th. Canaccord Genuity raised their price objective on SSR Mining from C$21.00 to C$22.00 in a report on Monday, April 23rd. Five research analysts have rated the stock with a buy rating, The company has an average rating of “Buy” and an average price target of C$16.18.
In other news, insider Jonathan Gilligan sold 27,875 shares of SSR Mining stock in a transaction on Friday, March 2nd. The stock was sold at an average price of C$7.17, for a total transaction of C$199,863.75. Also, Director Paul Benson purchased 10,000 shares of SSR Mining stock in a transaction dated Tuesday, March 13th. The shares were bought at an average price of C$11.62 per share, for a total transaction of C$116,200.00.
Hot Financial Stocks To Invest In Right Now: Express Scripts Holding Company(ESRX)
Advisors’ Opinion:
- [By Logan Wallace]
Brinker Capital Inc. increased its position in Express Scripts (NASDAQ:ESRX) by 11.3% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 84,842 shares of the company’s stock after purchasing an additional 8,605 shares during the quarter. Brinker Capital Inc.’s holdings in Express Scripts were worth $5,861,000 at the end of the most recent quarter.
- [By ]
The space that could come under the most pressure are the pharmacy benefit management players, an industry that thrives on the rebate system. Stocks to watch include: CVS Health (CVS) (owns PBM Caremark) and Express Scripts (ESRX) (and by extension Cigna (CI) , which is trying to acquire Express Scripts).
- [By Logan Wallace]
Schaper Benz & Wise Investment Counsel Inc. WI cut its holdings in shares of Express Scripts (NASDAQ:ESRX) by 2.0% during the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 85,515 shares of the company’s stock after selling 1,770 shares during the quarter. Schaper Benz & Wise Investment Counsel Inc. WI’s holdings in Express Scripts were worth $5,907,000 at the end of the most recent quarter.
- [By Alexander Bird]
Both CVS Health Corp. (NYSE: CVS) and Cigna Corp. (NYSE: CI) sank 5% while Express Scripts Holding Co. (NASDAQ: ESRX), one of the primary providers of pharmacy benefits, dropped 9.7% in response to the disruptive impact the announced partnership could have on the industry. Altogether, the healthcare sector lost a combined $30 billion in market share in the first two hours of trading today.
- [By Cory Renauer]
Sanofi took the assessment and started engaging end payers to see if any would offer easy reimbursement for a lower net price that reflects ICER’s assessment, and the industry listened. As of July 1, the partners will cut the net price of Praluent in return for straightforward access for around 25 million Americans covered by theExpress Scripts (NASDAQ:ESRX) national formulary. Thepharmacy benefits manager, and will also remove formulary access for its main competitor, Amgen’s (NASDAQ:AMGN) Repatha.
- [By ]
It may be unhealthy to trade drug stocks Friday. The word on Wall Street is to not expect too much from President Trump’s speech on drug prices. That means expect the unexpected, and prepare for a volatility spike in key healthcare names such as Express Scripts (ESRX) , CVS Health (CVS) , Endo International (ENDP) , Mallinckrodt (MNK) , McKesson (MCK) and Cardinal Health (CAH) .
Reports TheStreet’s Bill Meagher: “Evercore ISI may be an outlier as its analysts anticipate that recent speeches by officials from the Food and Drug Administration, Health and Human Services and Centers for Medicare & Medicaid Services may have telegraphed the Trump administration’s willingness to move beyond loud talk and tweets into policy discussions. In those tweets and in talks with his cabinet, Trump has been critical of the pharmaceutical sector and its pricing of prescription drugs, famously saying on at least two occasions that companies are “getting away with murder.”
Hot Financial Stocks To Invest In Right Now: Moneygram International, Inc.(MGI)
Advisors’ Opinion:
- [By ]
Moneygram (MGI) : “No, you need quality and this one doesn’t have it.”
Monster Beverage (MNST) : “I think this one has run out of gas so I’m going to say don’t buy. “
- [By ]
Cramer was bearish on Xilinx (XLNX) , Celgene (CELG) , Exelixis (EXEL) , Moneygram (MGI) , Monster Beverage (MNST) , SunCoke Energy Partners (SXCP) and Mattel (MAT) .
Hot Financial Stocks To Invest In Right Now: Magal Security Systems Ltd.(MAGS)
Advisors’ Opinion:
- [By Lisa Levin]
Magal Security Systems Ltd. (NASDAQ: MAGS) is expected to report earnings for its first quarter.
Four Seasons Education (Cayman) Inc. (NASDAQ: FEDU) is projected to report quarterly earnings at $0.04 per share on revenue of $11.74 million.
